$SBPH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in F-star Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in F-star Therapeutics, Inc.. Get notifications about new insider transactions in F-star Therapeutics, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 29 2016 | SBPH | Spring Bank Pharma ... | Bates Jonathan | Director | Option Exercise | A | 9.05 | 5,500 | 49,775 | 5,500 | |
| Jul 29 2016 | SBPH | Spring Bank Pharma ... | Arkowitz David | Director | Option Exercise | A | 9.05 | 5,500 | 49,775 | 5,500 | |
| May 20 2016 | SBPH | Spring Bank Pharma ... | Afdhal Nezam H. | Chief Medical Offic ... | Option Exercise | A | 10.97 | 5,000 | 54,850 | 5,000 | |
| May 20 2016 | SBPH | Spring Bank Pharma ... | Freve Jonathan | CFO, Treasurer & Se ... | Option Exercise | A | 10.97 | 17,209 | 188,783 | 17,209 | |
| May 20 2016 | SBPH | Spring Bank Pharma ... | Iyer Radhakrishnan P. | Chief Scientific Of ... | Option Exercise | A | 10.97 | 5,000 | 54,850 | 5,000 | |
| May 20 2016 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Option Exercise | A | 10.97 | 20,000 | 219,400 | 20,000 | |
| May 12 2016 | SBPH | Spring Bank Pharma ... | Eichler Kurt M | Director | Option Exercise | X | 9.00 | 10,416 | 93,744 | 0 | |
| May 12 2016 | SBPH | Spring Bank Pharma ... | Eichler Kurt M | Director | Option Exercise | X | 9.00 | 10,416 | 93,744 | 0 | |
| May 12 2016 | SBPH | Spring Bank Pharma ... | Eichler Kurt M | Director | Option Exercise | X | 9.00 | 10,416 | 93,744 | 0 | |
| May 12 2016 | SBPH | Spring Bank Pharma ... | Eichler Kurt M | Director | Option Exercise | X | 9.00 | 10,416 | 93,744 | 0 | |
| May 12 2016 | SBPH | Spring Bank Pharma ... | Eichler Kurt M | Director | Option Exercise | X | 8.00 | 9 | 72 | 0 | |
| May 12 2016 | SBPH | Spring Bank Pharma ... | Eichler Kurt M | Director | Option Exercise | X | 8.00 | 9 | 72 | 0 | |
| May 12 2016 | SBPH | Spring Bank Pharma ... | Eichler Kurt M | Director | Option Exercise | X | 8.00 | 9 | 72 | 0 | |
| May 12 2016 | SBPH | Spring Bank Pharma ... | Eichler Kurt M | Director | Option Exercise | X | 8.00 | 9 | 72 | 0 | |
| May 12 2016 | SBPH | Spring Bank Pharma ... | Eichler Kurt M | Director | Buy | X | 9.00 | 10,416 | 93,744 | 29,791 | 19.4 K to 29.8 K (+53.76 %) |
| May 12 2016 | SBPH | Spring Bank Pharma ... | Eichler Kurt M | Director | Buy | X | 9.00 | 10,416 | 93,744 | 29,791 | 19.4 K to 29.8 K (+53.76 %) |
| May 12 2016 | SBPH | Spring Bank Pharma ... | Eichler Kurt M | Director | Buy | X | 9.00 | 10,416 | 93,744 | 29,791 | 19.4 K to 29.8 K (+53.76 %) |
| May 12 2016 | SBPH | Spring Bank Pharma ... | Eichler Kurt M | Director | Buy | X | 9.00 | 10,416 | 93,744 | 29,791 | 19.4 K to 29.8 K (+53.76 %) |
| May 12 2016 | SBPH | Spring Bank Pharma ... | Eichler Kurt M | Director | Buy | X | 8.00 | 9,375 | 75,000 | 19,375 | 10 K to 19.4 K (+93.75 %) |
| May 12 2016 | SBPH | Spring Bank Pharma ... | Eichler Kurt M | Director | Buy | X | 8.00 | 9,375 | 75,000 | 19,375 | 10 K to 19.4 K (+93.75 %) |
| May 12 2016 | SBPH | Spring Bank Pharma ... | Eichler Kurt M | Director | Buy | X | 8.00 | 9,375 | 75,000 | 19,375 | 10 K to 19.4 K (+93.75 %) |
| May 12 2016 | SBPH | Spring Bank Pharma ... | Eichler Kurt M | Director | Buy | X | 8.00 | 9,375 | 75,000 | 19,375 | 10 K to 19.4 K (+93.75 %) |
| May 12 2016 | SBPH | Spring Bank Pharma ... | Eichler Kurt M | Director | Buy | P | 12.00 | 41,666 | 499,992 | 423,990 | 382.3 K to 424 K (+10.90 %) |
| May 12 2016 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Buy | P | 12.00 | 12,500 | 150,000 | 12,500 | 0 to 12.5 K |